Form 4: Pediatrix Medical Group Executive Reports Stock Transactions
SEC Form 4 Filing
Mary Ann E. Moore, EVP, General Counsel & Secretary of Pediatrix Medical Group, reports the disposition of shares to cover tax obligations upon vesting and holdings in a trust.
Summary
- On March 1, 2024, Mary Ann E. Moore, EVP, General Counsel & Secretary of Pediatrix Medical Group, Inc., reported a transaction involving common stock.
- 5,867 shares were disposed of at a price of $9.15 to cover tax obligations upon vesting of shares.
- Following the transaction, Moore directly owns 75,518 shares and indirectly owns 15,730 shares through a trust.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the executive's stock transactions related to vested shares and tax obligations.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of stock transaction (disposal of shares for tax obligations) |
| 03/05/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.